238 related articles for article (PubMed ID: 17387930)
21. [Effect of immunization on the quantitative behavior of gamma globulins in the blood serum of cattle following whole-body x-ray irradiation].
Koch F; Mehlhorn G; Neumeister K; Johannsen U; Panndorf H
Arch Exp Veterinarmed; 1980; 34(6):851-9. PubMed ID: 6163414
[TBL] [Abstract][Full Text] [Related]
22. A live vaccine 1-M-44 against Q-fever for oral use.
Genig VA
J Hyg Epidemiol Microbiol Immunol; 1968; 12(3):265-73. PubMed ID: 5753316
[No Abstract] [Full Text] [Related]
23. The Feasibility of Using
Kumaresan V; Alam S; Zhang Y; Zhang G
Front Immunol; 2021; 12():754690. PubMed ID: 34795669
[TBL] [Abstract][Full Text] [Related]
24. Observation on chemotherapy in cows chronically infected with Coxiella burnetii (Q fever).
Behymer D; Ruppanner R; Riemann HP; Biberstein EL; Franti CE
Folia Vet Lat; 1977; 7(1):64-70. PubMed ID: 885444
[TBL] [Abstract][Full Text] [Related]
25. Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against
Fratzke AP; Jan S; Felgner J; Liang L; Nakajima R; Jasinskas A; Manna S; Nihesh FN; Maiti S; Albin TJ; Esser-Kahn AP; Davies DH; Samuel JE; Felgner PL; Gregory AE
Front Immunol; 2021; 12():653092. PubMed ID: 33815413
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).
Kishimoto RA; Gonder JC; Johnson JW; Reynolds JA; Larson EW
Lab Anim Sci; 1981 Feb; 31(1):48-51. PubMed ID: 7253550
[TBL] [Abstract][Full Text] [Related]
27. Vaccination of cattle workers at risk of Q fever on the north coast of New South Wales.
Hutson B; Deaker RA; Newland J
Aust Fam Physician; 2000 Jul; 29(7):708-9. PubMed ID: 10914459
[TBL] [Abstract][Full Text] [Related]
28. Coxiella burnetii: host and bacterial responses to infection.
Waag DM
Vaccine; 2007 Oct; 25(42):7288-95. PubMed ID: 17825460
[TBL] [Abstract][Full Text] [Related]
29. The antibody response to antigens of Coxiella burneti.
Fiset P; Ormsbee RA
Zentralbl Bakteriol Orig; 1968 Apr; 206(3):321-9. PubMed ID: 5707314
[No Abstract] [Full Text] [Related]
30. Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine.
Kishimoto RA; Johnson JW; Kenyon RH; Ascher MS; Larson EW; Pedersen CE
Infect Immun; 1978 Jan; 19(1):194-8. PubMed ID: 624586
[TBL] [Abstract][Full Text] [Related]
31. Prevention of Coxiella burnetii shedding in infected dairy herds using a phase I C. burnetii inactivated vaccine.
Guatteo R; Seegers H; Joly A; Beaudeau F
Vaccine; 2008 Aug; 26(34):4320-8. PubMed ID: 18586060
[TBL] [Abstract][Full Text] [Related]
32. [Immunogenic value of various phase I Q vaccines prepared from various strains of Coxiella burneti].
Zarnea G; Crăcea E; Dumitresco S; Novac S; Mihancea N
Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):691-6. PubMed ID: 5742340
[No Abstract] [Full Text] [Related]
33. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
Waag DM; England MJ; Tammariello RF; Byrne WR; Gibbs P; Banfield CM; Pitt ML
Vaccine; 2002 Jun; 20(19-20):2623-34. PubMed ID: 12057622
[TBL] [Abstract][Full Text] [Related]
34. Immunization experiments with recombinant Coxiella burnetii proteins in a murine infection model.
Tyczka J; Eberling S; Baljer G
Ann N Y Acad Sci; 2005 Dec; 1063():143-8. PubMed ID: 16481505
[TBL] [Abstract][Full Text] [Related]
35. Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever.
Russell-Lodrigue KE; Zhang GQ; McMurray DN; Samuel JE
Infect Immun; 2006 Nov; 74(11):6085-91. PubMed ID: 17057087
[TBL] [Abstract][Full Text] [Related]
36. [An experimental study of the immunogenic and protective properties of Coxiella burnetii strain M-44 and a live enteral vaccine against Q fever].
Mikhaĭlov VV; Vorob'ev AA; Makhlaĭ AA; Khaltaeva GG; Suvorova TA; Krasnianskiĭ VP; Iakovlev EA; Pashanin IuG; Dykanov GA; Podkuĭko VN; Lebedinskaia EV
Zh Mikrobiol Epidemiol Immunobiol; 1996; (1):38-42. PubMed ID: 8820676
[TBL] [Abstract][Full Text] [Related]
37. Suitability of the microagglutination test for detection of post-infection and post-vaccination Q fever antibodies in human sera.
Kazár J; Brezina R; Schramek S; Palanová A; Tvrdá B
Acta Virol; 1981 Jul; 25(4):235-40. PubMed ID: 6116418
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of the Q fever vaccine: a meta-analysis.
Gefenaite G; Munster JM; van Houdt R; Hak E
Vaccine; 2011 Jan; 29(3):395-8. PubMed ID: 21094268
[TBL] [Abstract][Full Text] [Related]
39. Effect of lysozyme on the immune response of guinea pigs to the soluble phase 1 antigen of Coxiella burnetii.
Wachter RF; Briggs GP
Acta Virol; 1981 Jul; 25(4):241-4. PubMed ID: 6116419
[No Abstract] [Full Text] [Related]
40. Comparison of virulence of Coxiella burnetii isolates from bovine milk and from ticks.
Kocianová E; Kovácová EI; Literák I
Folia Parasitol (Praha); 2001; 48(3):235-9. PubMed ID: 11699660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
